Jennison Associates’s Emergent Biosolutions EBS Stock Holding History

Jennison Associates’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-162,550	Closed	-$15.1M	–	693
2021 Q1	$15.1M	Sell	162,550 -231,924	-59%	-$23.8M	0.01%	385
2020 Q4	$35.3M	Sell	394,474 -58,174	-13%	-$5.34M	0.03%	266
2020 Q3	$46.8M	Buy	452,648 +2,164	+0.5%	+$233K	0.04%	192
2020 Q2	$35.6M	Sell	450,484 -81,250	-15%	-$6.05M	0.03%	213
2020 Q1	$30.8M	Sell	531,734 -110,313	-17%	-$6.36M	0.04%	198
2019 Q4	$34.6M	Buy	642,047 +59,938	+10%	+$3.25M	0.03%	232
2019 Q3	$30.4M	Buy	582,109 +19,988	+4%	+$931K	0.03%	259
2019 Q2	$27.2M	Buy	562,121 +372,857	+197%	+$17.9M	0.03%	296
2019 Q1	$9.56M	Buy	+189,264	New	+$11.2M	0.01%	427

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates's EBS Position: Q2 2021 in Review

Jennison Associates sold out of Emergent Biosolutions (EBS) in Q2 2021, closing a stake of 162,550 shares — an estimated $15.1M sold.

Jennison Associates first reported a position in EBS in Q1 2019 and held it in 9 quarters. The position peaked at $46.8M in Q3 2020. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

Jennison Associates reported no remaining Emergent Biosolutions position as of Q2 2021 after selling out during the quarter.
Jennison Associates sold 162,550 Emergent Biosolutions shares in Q2 2021, an estimated $15.1M.
Jennison Associates first reported a position in Emergent Biosolutions in Q1 2019 and held it in 9 quarters.
Jennison Associates's Emergent Biosolutions position peaked at $46.8M in Q3 2020.
290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on Jennison Associates's 13F filing for Q2 2021, filed 12 Aug 2021.